PROS1 and viral infectious disease: It has been found that SARS-CoV-2 relies on the receptor-binding domain (RBD) of the S protein to bind to antibodies, and a subunit vaccine of the S protein lacking RBD can be designed to reduce ADE and prevent viral infection (54, 55).